The Future of Psychedelic Medicine | W. Bryan Hubbard

W. Bryan Hubbard joins Secretary Kennedy to discuss ibogaine and the future of psychedelic medicine. Hubbard is the chief executive officer of Americans for Ibogaine. He previously served as the first chairman and executive director of the Kentucky Opioid Abatement Advisory Commission, where his work addressing the opioid crisis led him to advocate for research into new approaches to addiction treatment. They discuss ibogaine's potential for opioid addiction, PTSD, and traumatic brain injury, the serious risks involved, and why rigorous scientific research is needed to determine whether these therapies are safe and effective.